Repligen | RGEN - Ebit



Repligen reported $5.96M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Agilent USD 394M 31M Jul/2025
Align Technology USD 163.03M 23.69M Jun/2025
Bio Techne USD -23860000 64.14M Jun/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Bruker USD 11.9M 89.8M Jun/2025
Charles River Laboratories USD 132.33M 55.89M Jun/2025
Danaher USD 760M 939M Jun/2025
Dentsply International USD 111M 23M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
General Electric Aerospace USD 1.94B 205M Jun/2025
Henry Schein USD -2050000000 2.23B Jun/2025
Illumina USD 331M 119M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Mettler Toledo International USD 265.44M 28.7M Jun/2025
Myriad Genetics USD -5500000 11.1M Mar/2025
Pfizer USD 2.6B 3.33B Jun/2025
Repligen USD 5.96M 17.45M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Standard Biotools USD -18273000 14.54M Jun/2025
Thermo Fisher Scientific USD 1.92B 353M Jun/2025
Waters USD 188.21M 19.32M Jun/2025
West Pharmaceutical Services USD 153.7M 28.7M Jun/2025